Diabetes and bone fragility: a dangerous liaison.
F Conti1, D T Wolosinska, G Pugliese
1Department of Molecular Medicine, University "Sapienza", Rome, Italy, francesco.conti@uniroma1.it.
Aging Clinical and Experimental Research
|August 3, 2013
Summary
Diabetes increases fracture risk due to poor bone quality, not just decreased bone mineral density. Maintaining good glycemic control is crucial for preserving bone health in diabetic patients.
Area of Science:
- Endocrinology
- Orthopedics
- Metabolic Diseases
Background:
- Diabetes mellitus is associated with an increased risk of fractures.
- Bone fragility in diabetic patients is not solely explained by decreased bone mineral density (BMD).
- Microvascular complications and increased fall risk contribute to fractures in long-standing diabetes.
Purpose of the Study:
- To elucidate the mechanisms by which diabetes impairs bone formation.
- To highlight the importance of glycemic control for bone health in diabetes.
- To review the effects of common diabetes medications on bone status.
Main Methods:
- Review of existing literature on diabetes and bone health.
- Analysis of pathways involved in bone metabolism affected by diabetes.
- Evaluation of the impact of diabetes medications on fracture risk.
Main Results:
- Diabetes negatively impacts bone quality through mechanisms including altered insulin growth factors, osteocalcin, and Wnt signaling.
- Hyperglycemia and AGE/RAGE axis alterations further impair bone formation.
- Certain diabetes medications like metformin, incretins, and DPP-4 inhibitors may have beneficial effects on bone.
Conclusions:
- Adequate glycemic control is essential for preserving bone health in diabetic individuals.
- Thiazolidinediones therapy requires caution due to an associated increased fracture risk.
- Understanding diabetes-related bone alterations is critical for fracture prevention strategies.
Related Concept Videos
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...